1
|
Wang Y, Ong J, Ng OW, Songkasupa T, Koh EY, Wong JPS, Puangjinda K, Fernandez CJ, Huangfu T, Ng LC, Chang SF, Yap HH. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1. Emerg Infect Dis 2022; 28:2446-2454. [PMID: 36417933 PMCID: PMC9707579 DOI: 10.3201/eid2812.220594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
African horse sickness (AHS) is a highly infectious and often fatal disease caused by 9 serotypes of the orbivirus African horse sickness virus (AHSV). In March 2020, an AHS outbreak was reported in Thailand in which AHSV serotype 1 was identified as the causative agent. Trivalent live attenuated vaccines serotype 1, 3, and 4 were used in a targeted vaccination campaign within a 50-km radius surrounding the infected cases, which promptly controlled the spread of the disease. However, AHS-like symptoms in vaccinated horses required laboratory diagnostic methods to differentiate infected horses from vaccinated horses, especially for postvaccination surveillance. We describe a real-time reverse transcription PCR-based assay for rapid characterization of the affecting field strain. The development and validation of this assay should imbue confidence in differentiating AHS-vaccinated horses from nonvaccinated horses. This method should be applied to determining the epidemiology of AHSV in future outbreaks.
Collapse
|
2
|
Bekker S, Huismans H, van Staden V. Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles. Viruses 2022; 14:1624. [PMID: 35893692 PMCID: PMC9331310 DOI: 10.3390/v14081624] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 07/12/2022] [Accepted: 07/21/2022] [Indexed: 02/06/2023] Open
Abstract
A unique characteristic of the African horse sickness virus (AHSV) major core protein VP7 is that it is highly insoluble, and spontaneously forms crystalline particles in AHSV-infected cells and when expressed in vitro. The aggregation of AHSV VP7 into these crystals presents many problems in AHSV vaccine development, and it is unclear whether VP7 aggregation affects AHSV assembly or contributes to AHSV pathogenesis. Here, we set out to abolish VP7 self-assembly by targeting candidate amino acid regions on the surface of the VP7 trimer via site-directed mutagenesis. It was found that the substitution of seven amino acids resulted in the complete disruption of AHSV VP7 self-assembly, which abolished the formation of VP7 crystalline particles and converted VP7 to a fully soluble protein still capable of interacting with VP3 to form core-like particles. This work provides further insight into the formation of AHSV VP7 crystalline particles and the successful development of AHSV vaccines. It also paves the way for future research by drawing comparisons with similar viral phenomena observed in human virology.
Collapse
Affiliation(s)
| | | | - Vida van Staden
- Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield 0083, South Africa; (S.B.); (H.H.)
| |
Collapse
|
3
|
Fairbanks EL, Brennan ML, Mertens PPC, Tildesley MJ, Daly JM. Re-parameterisation of a mathematical model of African horse sickness virus using data from a systematic literature search. Transbound Emerg Dis 2021; 69:e671-e681. [PMID: 34921513 PMCID: PMC9543668 DOI: 10.1111/tbed.14420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 09/29/2021] [Accepted: 09/29/2021] [Indexed: 11/26/2022]
Abstract
African horse sickness (AHS) is a vector‐borne disease transmitted by Culicoides spp., endemic to sub‐Saharan Africa. There have been many examples of historic and recent outbreaks in the Middle East, Asia and Europe. However, not much is known about infection dynamics and outbreak potential in these naive populations. In order to better inform a previously published ordinary differential equation model, we performed a systematic literature search to identify studies documenting experimental infection of naive (control) equids in vaccination trials. Data on the time until the onset of viraemia, clinical signs and death after experimental infection of a naive equid and duration of viraemia were extracted. The time to viraemia was 4.6 days and the time to clinical signs was 4.9 days, longer than the previously estimated latent period of 3.7 days. The infectious periods of animals that died/were euthanized or survived were found to be 3.9 and 8.7 days, whereas previous estimations were 4.4 and 6 days, respectively. The case fatality was also found to be higher than previous estimations. The updated parameter values (along with other more recently published estimates from literature) resulted in an increase in the number of host deaths, decrease in the duration of the outbreak and greater prevalence in vectors.
Collapse
Affiliation(s)
- Emma L Fairbanks
- School of Veterinary Medicine and Science, University of Nottingham, Loughborough, LE12 5RD, UK
| | - Marnie L Brennan
- School of Veterinary Medicine and Science, University of Nottingham, Loughborough, LE12 5RD, UK
| | - Peter P C Mertens
- School of Veterinary Medicine and Science, University of Nottingham, Loughborough, LE12 5RD, UK
| | - Michael J Tildesley
- The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, CV4 7AL, UK
| | - Janet M Daly
- School of Veterinary Medicine and Science, University of Nottingham, Loughborough, LE12 5RD, UK
| |
Collapse
|
4
|
Toh X, Wang Y, Rajapakse MP, Lee B, Songkasupa T, Suwankitwat N, Kamlangdee A, Judith Fernandez C, Huangfu T. Use of nanopore sequencing to characterize african horse sickness virus (AHSV) from the African horse sickness outbreak in thailand in 2020. Transbound Emerg Dis 2021; 69:1010-1019. [PMID: 33682298 DOI: 10.1111/tbed.14056] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2020] [Revised: 03/03/2021] [Accepted: 03/03/2021] [Indexed: 12/01/2022]
Abstract
African horse sickness (AHS) is a highly infectious and deadly disease despite availability of vaccines. Molecular characterization of African horse sickness virus (AHSV) detected from the March 2020 Thailand outbreak was carried out by whole-genome sequencing using Nanopore with a Sequence-Independent Single Primer Amplification (SISPA) approach. Nucleotide sequence of the whole genome was compared with closest matching AHSV strains using phylogenetic analyses and the AHSV-1 virus shared high sequence identity with isolates from the same outbreak. Substitution analysis revealed non-synonymous and synonymous substitutions in the VP2 gene as compared to circulating South African strains. The use of sequencing technologies, such as Nanopore with SISPA, has enabled rapid detection, identification and detailed genetic characterization of the AHS virus for informed decision-making and implementation of disease control measures. Active genetic information sharing has also allowed emergence of AHSV to be better monitored on a global basis.
Collapse
Affiliation(s)
- Xinyu Toh
- Center for Animal & Veterinary Sciences, Professional and Scientific Services, Animal and Veterinary Service, National Parks Board (NParks), Singapore
| | - Yifan Wang
- Center for Animal & Veterinary Sciences, Professional and Scientific Services, Animal and Veterinary Service, National Parks Board (NParks), Singapore
| | | | - Bernett Lee
- Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore
| | - Tapanut Songkasupa
- Virology section, Department of Livestock Development, National Institute of Animal Health, Bangkok, Thailand
| | - Nutthakarn Suwankitwat
- Virology section, Department of Livestock Development, National Institute of Animal Health, Bangkok, Thailand
| | - Attapon Kamlangdee
- Faculty of Veterinary Medicine, Kasetsart university, Kamphaengsean, Thailand
| | - Charlene Judith Fernandez
- Center for Animal & Veterinary Sciences, Professional and Scientific Services, Animal and Veterinary Service, National Parks Board (NParks), Singapore
| | - Taoqi Huangfu
- Center for Animal & Veterinary Sciences, Professional and Scientific Services, Animal and Veterinary Service, National Parks Board (NParks), Singapore
| |
Collapse
|
5
|
Dennis SJ, Meyers AE, Hitzeroth II, Rybicki EP. African Horse Sickness: A Review of Current Understanding and Vaccine Development. Viruses 2019; 11:E844. [PMID: 31514299 PMCID: PMC6783979 DOI: 10.3390/v11090844] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Revised: 08/30/2019] [Accepted: 09/04/2019] [Indexed: 01/05/2023] Open
Abstract
African horse sickness is a devastating disease that causes great suffering and many fatalities amongst horses in sub-Saharan Africa. It is caused by nine different serotypes of the orbivirus African horse sickness virus (AHSV) and it is spread by Culicoid midges. The disease has significant economic consequences for the equine industry both in southern Africa and increasingly further afield as the geographic distribution of the midge vector broadens with global warming and climate change. Live attenuated vaccines (LAV) have been used with relative success for many decades but carry the risk of reversion to virulence and/or genetic re-assortment between outbreak and vaccine strains. Furthermore, the vaccines lack DIVA capacity, the ability to distinguish between vaccine-induced immunity and that induced by natural infection. These concerns have motivated interest in the development of new, more favourable recombinant vaccines that utilize viral vectors or are based on reverse genetics or virus-like particle technologies. This review summarizes the current understanding of AHSV structure and the viral replication cycle and also evaluates existing and potential vaccine strategies that may be applied to prevent or control the disease.
Collapse
Affiliation(s)
- Susan J Dennis
- Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Rondebosch 7701, Cape Town, South Africa.
| | - Ann E Meyers
- Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Rondebosch 7701, Cape Town, South Africa.
| | - Inga I Hitzeroth
- Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Rondebosch 7701, Cape Town, South Africa.
| | - Edward P Rybicki
- Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Rondebosch 7701, Cape Town, South Africa.
- Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa.
| |
Collapse
|
6
|
Grewar JD, Weyer CT, Venter GJ, van Helden LS, Burger P, Guthrie AJ, Coetzee P, Labuschagne K, Bührmann G, Parker BJ, Thompson PN. A field investigation of an African horse sickness outbreak in the controlled area of South Africa in 2016. Transbound Emerg Dis 2018; 66:743-751. [PMID: 30449073 DOI: 10.1111/tbed.13077] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Revised: 07/01/2018] [Accepted: 11/08/2018] [Indexed: 11/30/2022]
Abstract
An outbreak of African horse sickness (AHS) caused by AHS virus type 1 occurred within the South African AHS surveillance zone during April and May 2016. The index case was detected by a private veterinarian through passive surveillance. There were 21 cases in total, which is relatively low compared to case totals during prior AHS outbreaks in the same region (and of the same AHS virus type) in 2004, 2011 and 2014. The affected proportion of horses on affected properties was 0.07 (95% CI 0.04, 0.11). Weather conditions were conducive to high midge activity immediately prior to the outbreak but midge numbers decreased rapidly with the advent of winter. The outbreak was localized, with 18 of the 21 cases occurring within 8 km of the index property and the three remaining cases on two properties within 21 km of the index property, with direction of spread consistent with wind-borne dispersion of infected midges. Control measures included implementation of a containment zone with movement restrictions on equids. The outbreak was attributed to a reversion to virulence of a live attenuated vaccine used extensively in South Africa. Outbreaks in the AHS control zones have a major detrimental impact on the direct export of horses from South Africa, notably to the European Union.
Collapse
Affiliation(s)
- John Duncan Grewar
- Epidemiology Section, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.,Equine Health Fund, Wits Health Consortium, Parktown, South Africa
| | - Camilla Theresa Weyer
- Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| | - Gert Johannes Venter
- Epidemiology, Parasites and Vectors, Agricultural Research Council- Onderstepoort Veterinary Research, Onderstepoort, South Africa
| | | | - Phillippa Burger
- Equine Health Fund, Wits Health Consortium, Parktown, South Africa
| | - Alan John Guthrie
- Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| | - Peter Coetzee
- Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| | - Karien Labuschagne
- Epidemiology, Parasites and Vectors, Agricultural Research Council- Onderstepoort Veterinary Research, Onderstepoort, South Africa
| | - Gary Bührmann
- Western Cape Veterinary Services, Elsenburg, South Africa
| | | | - Peter Neil Thompson
- Epidemiology Section, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| |
Collapse
|
7
|
Analysis of the three-dimensional structure of the African horse sickness virus VP7 trimer by homology modelling. Virus Res 2017; 232:80-95. [DOI: 10.1016/j.virusres.2017.02.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2016] [Revised: 01/27/2017] [Accepted: 02/02/2017] [Indexed: 01/21/2023]
|
8
|
Miranda JA, Steward GF. Variables influencing the efficiency and interpretation of reverse transcription quantitative PCR (RT-qPCR): An empirical study using Bacteriophage MS2. J Virol Methods 2016; 241:1-10. [PMID: 27940257 DOI: 10.1016/j.jviromet.2016.12.002] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Revised: 09/16/2016] [Accepted: 12/02/2016] [Indexed: 11/28/2022]
Abstract
Reverse transcription, quantitative PCR (RT-qPCR) is a sensitive method for quantification of specific RNA targets, but the first step of the assay, reverse transcription, is notoriously variable and sensitive to reaction conditions. In this study, we used purified Bacteriophage MS2 genomic RNA as a model virus target to test two different RT enzymes (SuperScript II and SuperScript III), two RT-priming strategies (gene-specific primers and random hexamers), and varying background RNA concentrations (0-50ngμl-1) to determine how these variables influence the efficiency of reverse transcription over a range of target concentrations (101-107 copies μl-1). The efficiency of the RT reaction was greatly improved by increasing both background RNA and primer concentrations, but the benefit provided by background RNA was source dependent. At a given target concentration, similar RT efficiencies were achieved with gene-specific primers and random hexamers, but the latter required much higher concentrations. With random hexamers, we observed a systematic variation in RT reaction efficiency as a function of target concentration. Using an RNA standard curve that was also subject to RT effectively normalized for this systematic variability, but the assay accuracy depended critically on the length of the standard RNA extending to the 3' end of the qPCR target site. Our results shed some light on previous contradictory conclusions in the literature, and provide insights that may aid in the design of RT-qPCR assays and the design of synthetic RNA standards when full-length material is not available.
Collapse
Affiliation(s)
- Jaclyn A Miranda
- Center for Microbial Oceanography: Research and Education, Department of Oceanography, University of Hawai'i at Mānoa, 1950 East-West Road, Honolulu, Hawai'i 96822, United States
| | - Grieg F Steward
- Center for Microbial Oceanography: Research and Education, Department of Oceanography, University of Hawai'i at Mānoa, 1950 East-West Road, Honolulu, Hawai'i 96822, United States.
| |
Collapse
|
9
|
Fowler VL, Howson ELA, Flannery J, Romito M, Lubisi A, Agüero M, Mertens P, Batten CA, Warren HR, Castillo-Olivares J. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Rapid Detection of African Horse Sickness Virus. Transbound Emerg Dis 2016; 64:1579-1588. [PMID: 27484889 PMCID: PMC5600106 DOI: 10.1111/tbed.12549] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2016] [Indexed: 12/24/2022]
Abstract
African horse sickness (AHS) is a disease of equids caused by African Horse Sickness Virus (AHSV) and is transmitted by Culicoides midges. AHS is endemic in sub‐Saharan Africa, but during the past century, outbreaks of significant economic importance and elevated mortality have been recorded in Northern African countries, the Iberian and Arabian Peninsula, the Middle East and the Indian subcontinent. Effective control combines the application of early warning systems, accurate laboratory diagnosis and reporting, animal movement restrictions, suitable vaccination and surveillance programs, and the coordination of all these measures by efficient veterinary services. Conventional reverse‐transcriptase (RT) PCR (RT‐PCR) and real‐time RT‐PCR (rRT‐PCR) assays have improved the sensitivity and rapidity of diagnosing AHS, resulting in the adoption of these methods as recommended tests by the World Organisation for Animal Health (OIE). However, currently these assays are only performed within laboratory settings; therefore, the development of field diagnostics for AHS would improve the fast implementation of control policies. Loop‐mediated isothermal amplification (LAMP) is an isothermal, autocycling, strand‐displacement nucleic acid amplification technique which can be performed in the field. LAMP assays are attractive molecular assays because they are simple to use, rapid, portable and have sensitivity and specificity within the range of rRT‐PCR. This study describes the development of a novel RT‐LAMP assay for the detection of AHSV. The AHSV RT‐LAMP assay has an analytical sensitivity of 96.1% when considering an rRT‐PCR cut‐off value of CT > 36, or 91.3% when no rRT‐PCR cut‐off is applied. Diagnostic sensitivity and specificity were 100%. This assay provides for a rapid and low cost AHS diagnostic for use in the field.
Collapse
Affiliation(s)
- V L Fowler
- The Pirbright Institute, Pirbright, Woking, Surrey, UK
| | - E L A Howson
- The Pirbright Institute, Pirbright, Woking, Surrey, UK
| | - J Flannery
- The Pirbright Institute, Pirbright, Woking, Surrey, UK
| | - M Romito
- ARC-Onderstepoort Veterinary Institute, Onderstepoort, South Africa
| | - A Lubisi
- ARC-Onderstepoort Veterinary Institute, Onderstepoort, South Africa
| | - M Agüero
- Laboratorio Central de Veterinaria-Sanidad Animal, Algete (Madrid), Spain
| | - P Mertens
- The Pirbright Institute, Pirbright, Woking, Surrey, UK
| | - C A Batten
- The Pirbright Institute, Pirbright, Woking, Surrey, UK
| | - H R Warren
- OptiGene Limited, Horsham, West Sussex, UK
| | | |
Collapse
|
10
|
Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes. J Virol 2016; 90:7405-7414. [PMID: 27279609 PMCID: PMC4984648 DOI: 10.1128/jvi.00548-16] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Accepted: 05/25/2016] [Indexed: 01/03/2023] Open
Abstract
African horse sickness virus (AHSV), an orbivirus in the Reoviridae family with nine different serotypes, causes devastating disease in equids. The virion particle is composed of seven proteins organized in three concentric layers, an outer layer made of VP2 and VP5, a middle layer made of VP7, and inner layer made of VP3 that encloses a replicase complex of VP1, VP4, and VP6 and a genome of 10 double-stranded RNA segments. In this study, we sought to develop highly efficacious candidate vaccines against all AHSV serotypes, taking into account not only immunogenic and safety properties but also virus productivity and stability parameters, which are essential criteria for vaccine candidates. To achieve this goal, we first established a highly efficient reverse genetics (RG) system for AHSV serotype 1 (AHSV1) and, subsequently, a VP6-defective AHSV1 strain in combination with in trans complementation of VP6. This was then used to generate defective particles of all nine serotypes, which required the exchange of two to five RNA segments to achieve equivalent titers of particles. All reassortant-defective viruses could be amplified and propagated to high titers in cells complemented with VP6 but were totally incompetent in any other cells. Furthermore, these replication-incompetent AHSV particles were demonstrated to be highly protective against homologous virulent virus challenges in type I interferon receptor (IFNAR)-knockout mice. Thus, these defective viruses have the potential to be used for the development of safe and stable vaccine candidates. The RG system also provides a powerful tool for the study of the role of individual AHSV proteins in virus assembly, morphogenesis, and pathogenesis. IMPORTANCE African horse sickness virus is transmitted by biting midges and causes African horse sickness in equids, with mortality reaching up to 95% in naive horses. Therefore, the development of efficient vaccines is extremely important due to major economic losses in the equine industry. Through the establishment of a highly efficient RG system, replication-deficient viruses of all nine AHSV serotypes were generated. These defective viruses achieved high titers in a cell line complemented with VP6 but failed to propagate in wild-type mammalian or insect cells. Importantly, these candidate vaccine strains showed strong protective efficacy against AHSV infection in an IFNAR−/− mouse model.
Collapse
|
11
|
de Waal T, Liebenberg D, Venter GJ, Mienie CM, van Hamburg H. Detection of African horse sickness virus in Culicoides imicola pools using RT-qPCR. JOURNAL OF VECTOR ECOLOGY : JOURNAL OF THE SOCIETY FOR VECTOR ECOLOGY 2016; 41:179-185. [PMID: 27232141 DOI: 10.1111/jvec.12210] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2015] [Accepted: 04/01/2016] [Indexed: 06/05/2023]
Abstract
African horse sickness (AHS) is an infectious, non-contagious arthropod-borne disease of equids, caused by the African horse sickness virus (AHSV), an orbivirus of the Reoviridae family. It is endemic in sub-Saharan Africa and thought to be the most lethal viral disease of horses. This study focused on detection of AHSV in Culicoides imicola (Diptera: Ceratopogonidae) pools by the application of a RT-qPCR. Midges were fed on AHSV-infected blood. A single blood-engorged female was allocated to pools of unfed nulliparous female midges. Pool sizes varied from 1 to 200. RNA was extracted and prepared for RT-qPCR. The virus was successfully detected and the optimal pool size for the limit of detection of the virus was determined at a range between 1 to 25. Results from this investigation highlight the need for a standardized protocol for AHSV investigation in Culicoides midges especially for comparison among different studies and for the determination of infection rate.
Collapse
Affiliation(s)
- Tania de Waal
- Unit for Environmental Sciences and Management, North-West University, Potchefstroom campus, Private Bag X6001, Potchefstroom 2520, South Africa
| | - Danica Liebenberg
- Unit for Environmental Sciences and Management, North-West University, Potchefstroom campus, Private Bag X6001, Potchefstroom 2520, South Africa.
- Faculty of Education Sciences, School for Natural Sciences and Technology for Education, North-West University, Potchefstroom campus, Private Bag X6001, Potchefstroom 2520, South Africa.
| | - Gert J Venter
- Parasites, Vectors and Vector Borne diseases, Agricultural Research Council- Onderstepoort Veterinary Institute, Private Bag X5, Onderstepoort 0110, South Africa
| | - Charlotte Ms Mienie
- Unit for Environmental Sciences and Management, North-West University, Potchefstroom campus, Private Bag X6001, Potchefstroom 2520, South Africa
| | - Huib van Hamburg
- Unit for Environmental Sciences and Management, North-West University, Potchefstroom campus, Private Bag X6001, Potchefstroom 2520, South Africa
| |
Collapse
|
12
|
Weyer CT, Joone C, Lourens CW, Monyai MS, Koekemoer O, Grewar JD, van Schalkwyk A, Majiwa PO, MacLachlan NJ, Guthrie AJ. Development of three triplex real-time reverse transcription PCR assays for the qualitative molecular typing of the nine serotypes of African horse sickness virus. J Virol Methods 2015; 223:69-74. [DOI: 10.1016/j.jviromet.2015.07.015] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Revised: 07/14/2015] [Accepted: 07/27/2015] [Indexed: 11/25/2022]
|
13
|
Alberca B, Bachanek-Bankowska K, Cabana M, Calvo-Pinilla E, Viaplana E, Frost L, Gubbins S, Urniza A, Mertens P, Castillo-Olivares J. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. Vaccine 2014; 32:3670-4. [PMID: 24837765 PMCID: PMC4061461 DOI: 10.1016/j.vaccine.2014.04.036] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 04/01/2014] [Accepted: 04/14/2014] [Indexed: 11/15/2022]
Abstract
A recombinant modified Vaccinia Ankara virus expressing VP2 of African horse sickness virus serotype 9 was generated. Four horses were vaccinated on days 0 and 20. Three unvaccinated controls were used. Vaccinated and control horses were challenged intravenously with 107.4TCID50 of AHSV-9 on day 34 of the study. At challenge, vaccinates had virus neutralising antibodies but were negative for antibodies to AHSV-VP7. All vaccinates were completely protected against clinical signs of African horse sickness.
African horse sickness virus (AHSV) is an arthropod-borne pathogen that infects all species of equidae and causes high mortality in horses. Previously, a recombinant modified vaccinia Ankara (MVA) virus expressing the protein VP2 of AHSV serotype 4 was shown to induce virus neutralising antibodies in horses and protected interferon alpha receptor gene knock-out mice (IFNAR −/−) against virulent AHSV challenge. This study builds on the previous work, examining the protective efficacy of MVA-VP2 vaccination in the natural host of AHSV infection. A study group of 4 horses was vaccinated twice with a recombinant MVA virus expressing the major capsid protein (VP2) of AHSV serotype 9. Vaccinated animals and a control group of unvaccinated horses were then challenged with a virulent strain of AHSV-9. The vaccinated animals were completely protected against clinical disease and also against viraemia as measured by standard end-point dilution assays. In contrast, all control horses presented viraemia after challenge and succumbed to the infection. These results demonstrate the potential of recombinant MVA viruses expressing the outer capsid VP2 of AHSV as a protective vaccine against AHSV infection in the field.
Collapse
Affiliation(s)
- Berta Alberca
- Zoetis-Spain, Ctra de Comprodon, Finca La Riba, 17813 Vall de Bianya, Girona, Spain
| | | | - Marta Cabana
- Zoetis-Spain, Ctra de Comprodon, Finca La Riba, 17813 Vall de Bianya, Girona, Spain
| | - Eva Calvo-Pinilla
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, Surrey, UK
| | - Elisenda Viaplana
- Zoetis-Spain, Ctra de Comprodon, Finca La Riba, 17813 Vall de Bianya, Girona, Spain
| | - Lorraine Frost
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, Surrey, UK
| | - Simon Gubbins
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, Surrey, UK
| | - Alicia Urniza
- Zoetis-Spain, Ctra de Comprodon, Finca La Riba, 17813 Vall de Bianya, Girona, Spain
| | - Peter Mertens
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, Surrey, UK
| | | |
Collapse
|
14
|
Bachanek-Bankowska K, Maan S, Castillo-Olivares J, Manning NM, Maan NS, Potgieter AC, Di Nardo A, Sutton G, Batten C, Mertens PPC. Real time RT-PCR assays for detection and typing of African horse sickness virus. PLoS One 2014; 9:e93758. [PMID: 24721971 PMCID: PMC3983086 DOI: 10.1371/journal.pone.0093758] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2013] [Accepted: 03/05/2014] [Indexed: 12/25/2022] Open
Abstract
Although African horse sickness (AHS) can cause up to 95% mortality in horses, naïve animals can be protected by vaccination against the homologous AHSV serotype. Genome segment 2 (Seg-2) encodes outer capsid protein VP2, the most variable of the AHSV proteins. VP2 is also a primary target for AHSV specific neutralising antibodies, and consequently determines the identity of the nine AHSV serotypes. In contrast VP1 (the viral polymerase) and VP3 (the sub-core shell protein), encoded by Seg-1 and Seg-3 respectively, are highly conserved, representing virus species/orbivirus-serogroup-specific antigens. We report development and evaluation of real-time RT-PCR assays targeting AHSV Seg-1 or Seg-3, that can detect any AHSV type (virus species/serogroup-specific assays), as well as type-specific assays targeting Seg-2 of the nine AHSV serotypes. These assays were evaluated using isolates of different AHSV serotypes and other closely related orbiviruses, from the ‘Orbivirus Reference Collection’ (ORC) at The Pirbright Institute. The assays were shown to be AHSV virus-species-specific, or type-specific (as designed) and can be used for rapid, sensitive and reliable detection and identification (typing) of AHSV RNA in infected blood, tissue samples, homogenised Culicoides, or tissue culture supernatant. None of the assays amplified cDNAs from closely related heterologous orbiviruses, or from uninfected host animals or cell cultures.
Collapse
Affiliation(s)
| | - Sushila Maan
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Javier Castillo-Olivares
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Nicola M. Manning
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Narender Singh Maan
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Abraham C. Potgieter
- Deltamune (Pty) Ltd, Lyttelton, Centurion, South Africa
- Department of Biochemistry, Centre for Human Metabonomics, North-West University, Private Bag X6001, Potchefstroom, South Africa
| | - Antonello Di Nardo
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Geoff Sutton
- Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
| | - Carrie Batten
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
| | - Peter P. C. Mertens
- Vector-borne Viral Diseases Programme, The Pirbright Institute, Pirbright, Surrey, United Kingdom
- * E-mail:
| |
Collapse
|
15
|
Grewar JD, Weyer CT, Guthrie AJ, Koen P, Davey S, Quan M, Visser D, Russouw E, Bührmann G. The 2011 outbreak of African horse sickness in the African horse sickness controlled area in South Africa. J S Afr Vet Assoc 2013. [DOI: 10.4102/jsava.v84i1.973] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
African horse sickness (AHS) is a controlled animal disease in South Africa, and as a result of the high mortality rates experienced, outbreaks in the AHS controlled area in the Western Cape Province have a significant impact on affected properties as well as on the exportation of live horses from the AHS free zone in metropolitan Cape Town. An outbreak of AHS serotype 1 occurred in the surveillance zone of the AHS controlled area of the Western Cape during the summer of 2011. The epicentre of the outbreak was the town of Mamre in the magisterial district of Malmesbury and the outbreak was confined to a defined containment zone within this area by movement control of all equids and a blanket vaccination campaign. A total of 73 cases of AHS were confirmed during this outbreak, which included four confirmed subclinical cases. The morbidity rate for the outbreak was 16%with a mortality rate of 14%and a case fatality rate of 88%. Outbreak disease surveillance relied on agent identification using polymerase chain reaction (PCR)-based assays, which is novel for an AHS outbreak in South Africa. The source of this outbreak was never confirmed although it is believed to be associated with the illegal movement of an infected animal into the Mamre area. This detailed description of the outbreak provides a sound scientific basis to assist decision making in future AHS outbreaks in the AHS controlled area of South Africa and in countries where AHS is an exotic or emerging disease.
Collapse
|
16
|
Rathogwa NM, Quan M, Smit JQ, Lourens C, Guthrie AJ, van Vuuren M. Development of a real time polymerase chain reaction assay for equine encephalosis virus. J Virol Methods 2013; 195:205-10. [PMID: 24161811 DOI: 10.1016/j.jviromet.2013.10.018] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2013] [Revised: 10/06/2013] [Accepted: 10/08/2013] [Indexed: 11/24/2022]
Abstract
Equine encephalosis virus (EEV) is the cause of equine encephalosis. The disease is similar to mild forms of African horse sickness (AHS) and the two diseases are easily confused. Laboratory identification and serotyping of EEV is based on viral isolation in BHK-21 cells and a viral plaque inhibition neutralisation test. These procedures are time-consuming and therefore a more rapid diagnostic assay for EEV that can distinguish EEV from African horse sickness virus (AHSV) infections was developed. The S7 (VP7) gene from 38 EEV isolates representing all seven serotypes was amplified and sequenced. A conserved region at the 5' end of the gene was identified and used to design group-specific EEV primers and a TaqMan(®) MGB™ hydrolysis probe. The efficiency of the EEV real-time RT-PCR assay was 81%. The assay was specific, as it did not detect any of the nine serotypes of AHSV, nor 24 serotypes of bluetongue virus (BTV) and sensitive, with a 95% limit of detection of 10(2.9) TCID50/ml blood (95% confidence interval: 10(2.7) to 10(3.3)). The real-time format was selected because of its convenience, sensitivity and ability to produce results rapidly.
Collapse
Affiliation(s)
- N M Rathogwa
- Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
| | | | | | | | | | | |
Collapse
|
17
|
Van Sittert SJ, Drew TM, Kotze JL, Strydom T, Weyer CT, Guthrie AJ. Occurrence of African horse sickness in a domestic dog without apparent ingestion of horse meat. J S Afr Vet Assoc 2013. [DOI: 10.4102/jsava.v84i1.948] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
This is the first case of African horse sickness (AHS) in a dog where there was no apparent ingestion of horse meat. Significantly, the dog was part of a colony that resides in a Good Clinical Practice and Good Laboratory Practice accredited facility where complete history, weather and feeding records are maintained. The dog died after a week-long illness despite therapy. The principal post-mortem findings were severe hydrothorax and pulmonary consolidation (red hepatisation of the lungs). Histopathology revealed severe oedema and congestion of the lungs, hyaline degeneration of the myocardium and congestion of the liver sinusoids. Immunohistochemistry detected AHS-positive staining granules in the myocardium, whilst a real-time reverse transcription quantitative Polymerase chain reaction assay of tissue samples was strongly positive for African horse sickness virus nucleic acid. Other dogs on the property showed a 43%seroconversion rate to AHS.
Collapse
|
18
|
Guthrie AJ, MacLachlan NJ, Joone C, Lourens CW, Weyer CT, Quan M, Monyai MS, Gardner IA. Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus. J Virol Methods 2013; 189:30-5. [DOI: 10.1016/j.jviromet.2012.12.014] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2012] [Accepted: 12/10/2012] [Indexed: 10/27/2022]
|
19
|
Weyer CT, Quan M, Joone C, Lourens CW, MacLachlan NJ, Guthrie AJ. African horse sickness in naturally infected, immunised horses. Equine Vet J 2012; 45:117-9. [PMID: 22612775 DOI: 10.1111/j.2042-3306.2012.00590.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
To determine whether subclinical cases, together with clinical cases, of African horse sickness (AHS) occur in immunised horses in field conditions, whole blood samples were collected and rectal temperatures recorded weekly from 50 Nooitgedacht ponies resident in open camps at the Faculty of Veterinary Science, University of Pretoria, Onderstepoort, during 2008-2010. The samples were tested for the presence of African horse sickness virus (AHSV) RNA by a recently developed real-time RT-PCR. It was shown that 16% of immunised horses in an AHS endemic area were infected with AHSV over a 2 year period, with half of these (8%) being subclinically infected. The potential impact of such cases on the epidemiology of AHS warrants further investigation.
Collapse
Affiliation(s)
- C T Weyer
- Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa
| | | | | | | | | | | |
Collapse
|
20
|
Comparison of two trapping methods for Culicoides biting midges and determination of African horse sickness virus prevalence in midge populations at Onderstepoort, South Africa. Vet Parasitol 2012; 185:265-73. [DOI: 10.1016/j.vetpar.2011.09.037] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2011] [Revised: 08/02/2011] [Accepted: 09/26/2011] [Indexed: 11/20/2022]
|
21
|
Rapid molecular detection methods for arboviruses of livestock of importance to northern Europe. J Biomed Biotechnol 2011; 2012:719402. [PMID: 22219660 PMCID: PMC3246798 DOI: 10.1155/2012/719402] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2011] [Revised: 10/14/2011] [Accepted: 10/25/2011] [Indexed: 11/18/2022] Open
Abstract
Arthropod-borne viruses (arboviruses) have been responsible for some of the most explosive epidemics of emerging infectious diseases over the past decade. Their impact on both human and livestock populations has been dramatic. The early detection either through surveillance or diagnosis of virus will be a critical feature in responding and resolving the emergence of such epidemics in the future. Although some of the most important emerging arboviruses are human pathogens, this paper aims to highlight those diseases that primarily affect livestock, although many are zoonotic and some occasionally cause human mortality. This paper also highlights the molecular detection methods specific to each virus and identifies those emerging diseases for which a rapid detection methods are not yet developed.
Collapse
|
22
|
Belaganahalli MN, Maan S, Maan NS, Tesh R, Attoui H, Mertens PPC. Umatilla virus genome sequencing and phylogenetic analysis: identification of stretch lagoon orbivirus as a new member of the Umatilla virus species. PLoS One 2011; 6:e23605. [PMID: 21897849 PMCID: PMC3163642 DOI: 10.1371/journal.pone.0023605] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2011] [Accepted: 07/20/2011] [Indexed: 11/19/2022] Open
Abstract
The genus Orbivirus, family Reoviridae, includes 22 species of viruses with genomes composed of ten segments of linear dsRNA that are transmitted between their vertebrate hosts by insects or ticks, or with no identified vectors. Full-genome sequence data are available for representative isolates of the insect borne mammalian orbiviruses (including bluetongue virus), as well as a tick borne avian orbivirus (Great Island virus). However, no sequence data are as yet available for the mosquito borne avian orbiviruses.We report full-length, whole-genome sequence data for Umatilla virus (UMAV), a mosquito borne avian orbivirus from the USA, which belongs to the species Umatilla virus. Comparisons of conserved genome segments 1, 2 and 8 (Seg-1, Seg-2 and Seg-8) - encoding the polymerase-VP1, sub-core 'T2' protein and core-surface 'T13' protein, respectively, show that UMAV groups with the mosquito transmitted mammalian orbiviruses. The highest levels of sequence identity were detected between UMAV and Stretch Lagoon orbivirus (SLOV) from Australia, showing that they belong to the same virus species (with nt/aa identity of 76.04%/88.07% and 77.96%/95.36% in the polymerase and T2 genes and protein, respectively). The data presented here has assisted in identifying the SLOV as a member of the Umatilla serogroup. This sequence data reported here will also facilitate identification of new isolates, and epidemiological studies of viruses belonging to the species Umatilla virus.
Collapse
Affiliation(s)
| | - Sushila Maan
- Vector-borne Diseases Programme, Institute for Animal Health, Surrey, United Kingdom
| | - Narender S. Maan
- Vector-borne Diseases Programme, Institute for Animal Health, Surrey, United Kingdom
| | - Robert Tesh
- Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Houssam Attoui
- Vector-borne Diseases Programme, Institute for Animal Health, Surrey, United Kingdom
| | - Peter P. C. Mertens
- Vector-borne Diseases Programme, Institute for Animal Health, Surrey, United Kingdom
- * E-mail:
| |
Collapse
|
23
|
A new duplex real-time RT-PCR assay for sensitive and specific detection of African horse sickness virus. Mol Cell Probes 2011; 25:87-93. [PMID: 21315146 DOI: 10.1016/j.mcp.2011.01.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2010] [Revised: 01/18/2011] [Accepted: 01/21/2011] [Indexed: 11/23/2022]
Abstract
A new real-time reverse transcription-polymerase chain reaction (RT-PCR) assay for a simple and rapid diagnosis of African Horse Sickness (AHS) was developed. Primers and FAM-labeled TaqMan-MGB probes specific for African horse sickness virus (AHSV) were selected from the consensus sequence of the segment 8 of all 9 serotypes of AHSV reference strains. For the determination of the analytical sensitivity, an in vitro transcript (AHS_ns2T7) of the target region was constructed and tested. Furthermore, the AHS_ns2T7 transcript was used either as positive control or as a standard for quantifying target copies. A commercial heterologous Armored RNA was used as an internal positive control (IPC) for both RNA isolation and RT-PCR steps. The qRT-PCR AHS_ns2 was able to amplify the target sequence up to 0.71 copies/reaction. Its flexibility allowed to amplify a wide dynamic range of RNA copies from 1.5 to 0.001fg. Within this range, the Ct values varied from 18 to 38 cycles with SD values always lower than 0.5 confirming their strong and constant linear correlation with the RNA target. Furthermore the newly designed duplex real-time RT-PCR proved to be strictly AHSV-specific as it did not amplify close related viruses.
Collapse
|
24
|
Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB assay for the detection of T. equi. Vet Parasitol 2010; 172:33-45. [PMID: 20493635 DOI: 10.1016/j.vetpar.2010.04.025] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2009] [Revised: 04/08/2010] [Accepted: 04/19/2010] [Indexed: 11/22/2022]
Abstract
Although a quantitative real-time PCR assay (qPCR) assay for the detection of Theileria equi has been developed and evaluated, it is possible that additional, as yet undetected 18S rRNA gene sequence variants may exist. A qPCR assay targeting a different gene, used in conjunction with the T. equi 18S rRNA qPCR assay, could assist in the detection of all T. equi genotypes in field samples. A T. equi ema-1-specific qPCR (Ueti et al., 2003) was tested on 107 South African field samples, 90 of which tested positive for T. equi antibody using the immuno-fluorescent antibody test (IFAT). The qPCR assay performed poorly, as T. equi was detected in only 67 of the 90 IFAT-positive field samples at quantification cycle (C(q)) values ranging from 27 to 39.95. Furthermore, a high C(q) value of 36.18 was obtained from DNA extracted from a South African in vitro-cultured T. equi WL isolate [1.38% parasitized erythrocytes (PE)] when a low C(q) value (indicative of a high T. equi DNA concentration) was expected. Approximately 600 bp of the ema-1 gene from 38 South African samples were sequenced and BLASTN analysis confirmed all sequences to be merozoite surface protein genes, with an identity of 87.1-100% to previously published T. equi ema-1 gene sequences. Alignment of the sequences revealed extensive sequence variations in the target regions of the primers and probes (Ueti et al., 2003), explaining the poor performance of the qPCR assay. Based on these observations, we developed a new TaqMan minor-groove binder (MGB) probe-based qPCR assay, targeting a more conserved region of the ema-1 gene. This assay was shown to be efficient and specific, and the detection limit, defined as the concentration at which 95% of T. equi-positive samples are detected, was determined to be 1.4 x 10(-4)% PE. The two ema-1 assays were compared by testing 41 South African field samples in parallel. The results suggested that the new assay was more sensitive than the original assay, as T. equi was detected in more samples and at lower C(q) values when the new assay was used. Phylogenetic analyses of the 18S rRNA gene sequences and ema-1 amino acid sequences from the same samples showed inconsistencies between the clades, indicating that the T. equi 18S rRNA genetic groups previously identified in South Africa may not represent distinct T. equi lineages. It is possible that the different T. equi ema-1 genotypes could be related to antigenic variability and pathogenicity and may be associated with clinical differences in equine piroplasmosis cases, but this remains to be elucidated.
Collapse
|